Most Recent Posts
Not surprisingly, PhRMA was not alone in objecting to the one-sided article on clinical trials which was recently featured on the front page of the
In November, the President's Council of Advisors on Science and Technology (PCAST) issued a report focusing on what they view as the necessary steps to
Yesterday the Congressional Budget Office (CBO) released a report describing revised methodology for estimating the fi
In honor of National Diabetes Awareness Month, we want to share with you the story of a recently diagnosed Type II Diabetes patient and her experience with a prescription assistance program:
This week I'm in Boston attending the Harvard Personalized Medicine Conference.